Literature DB >> 8520724

The twitcher mouse: a model for Krabbe disease and for experimental therapies.

K Suzuki1, K Suzuki1.   

Abstract

The twitcher is a naturally-occurring mouse mutant caused by an abnormality in the gene coded for galactosylceramidase. It is therefore genetically equivalent to human globoid cell leukodystrophy (Krabbe disease). Affected mice develop clinical symptoms at the onset of the active myelination period and, if untreated, die by 35 +/- days. The pathology is very similar to that in human disease. Toxicity of galactosylsphingosine (psychosine) that accumulates abnormally in the nervous system is considered to be primarily responsible for the pathogenesis. Transplantation of bone marrow cells from normal donors is partially effective and triples the life span of affected mice to 100 +/- days with evidence of remyelination in the CNS. The mutation responsible for the twitcher mutant has recently been identified. It is expected that this model will be useful for basic studies on treatment of this group of genetic disorders affecting the brain through transgenic and/or gene therapy approaches.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8520724     DOI: 10.1111/j.1750-3639.1995.tb00601.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  33 in total

1.  4th Symposium on Probing Disorders of the White Matter. Abstracts.

Authors: 
Journal:  J Mol Neurosci       Date:  1999-06       Impact factor: 3.444

Review 2.  Leukodystrophy and bone marrow transplantation: role of mixed hematopoietic chimerism.

Authors:  C L Kaufman; S T Ildstad
Journal:  Neurochem Res       Date:  1999-04       Impact factor: 3.996

3.  Mesenchymal lineage stem cells have pronounced anti-inflammatory effects in the twitcher mouse model of Krabbe's disease.

Authors:  Cynthia B Ripoll; Mette Flaat; Jessica Klopf-Eiermann; Jeanne M Fisher-Perkins; Cynthia B Trygg; Brittni A Scruggs; Marjorie L McCants; Helen Paige Leonard; Amy F Lin; Shijia Zhang; Michelle E Eagle; Xavier Alvarez; Yu Teh Li; Su Chen Li; Jeffrey M Gimble; Bruce A Bunnell
Journal:  Stem Cells       Date:  2011-01       Impact factor: 6.277

Review 4.  A microglial hypothesis of globoid cell leukodystrophy pathology.

Authors:  Alexandra M Nicaise; Ernesto R Bongarzone; Stephen J Crocker
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

5.  Quantitative Microproteomics Based Characterization of the Central and Peripheral Nervous System of a Mouse Model of Krabbe Disease.

Authors:  Davide Pellegrini; Ambra Del Grosso; Lucia Angella; Nadia Giordano; Marialaura Dilillo; Ilaria Tonazzini; Matteo Caleo; Marco Cecchini; Liam A McDonnell
Journal:  Mol Cell Proteomics       Date:  2019-03-29       Impact factor: 5.911

Review 6.  Animal models of lysosomal disease: an overview.

Authors:  K Suzuki; J E Månsson
Journal:  J Inherit Metab Dis       Date:  1998-08       Impact factor: 4.982

Review 7.  Gene therapy for lysosomal storage diseases (LSDs) in large animal models.

Authors:  Mark Haskins
Journal:  ILAR J       Date:  2009

8.  Region- and age-dependent alterations of glial-neuronal metabolic interactions correlate with CNS pathology in a mouse model of globoid cell leukodystrophy.

Authors:  Tore Wergeland Meisingset; Alessandra Ricca; Margherita Neri; Ursula Sonnewald; Angela Gritti
Journal:  J Cereb Blood Flow Metab       Date:  2013-04-24       Impact factor: 6.200

Review 9.  Treatment of lysosomal storage disorders: cell therapy and gene therapy.

Authors:  Y Eto; J-S Shen; X-L Meng; T Ohashi
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

10.  Clinical and immunopathologic alterations in rhesus macaques affected with globoid cell leukodystrophy.

Authors:  Juan T Borda; Xavier Alvarez; Mahesh Mohan; Marion S Ratterree; Kathrine Phillippi-Falkenstein; Andrew A Lackner; Bruce A Bunnell
Journal:  Am J Pathol       Date:  2007-12-28       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.